Literature DB >> 20869073

The immunomodulatory properties of mesenchymal stem cells: implications for surgical disease.

Brent R Weil1, Mariuxi C Manukyan, Jeremy L Herrmann, Aaron M Abarbanell, Jeffrey A Poynter, Yue Wang, Daniel R Meldrum.   

Abstract

Mesenchymal stem cells (MSCs) have been used experimentally and clinically in the treatment of a wide variety of pathologies. It is now clear that a number of different mechanisms contribute to the therapeutic effects exerted by these cells. The ability of MSCs to interact with and modulate the functions of a wide variety of immune cells has been recognized as one such mechanism. The implications that the immunomodulatory properties of MSCs may have for the treatment of solid organ rejection, the Systemic Inflammatory Response Syndrome, cancer, and Crohn's disease are reviewed herein.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20869073      PMCID: PMC3011048          DOI: 10.1016/j.jss.2010.07.019

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  72 in total

Review 1.  Mixed chimerism and transplant tolerance.

Authors:  M Sykes
Journal:  Immunity       Date:  2001-04       Impact factor: 31.745

2.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

3.  Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.

Authors:  Amelia Bartholomew; Cord Sturgeon; Mandy Siatskas; Karen Ferrer; Kevin McIntosh; Sheila Patil; Wayne Hardy; Steve Devine; David Ucker; Robert Deans; Annemarie Moseley; Ronald Hoffman
Journal:  Exp Hematol       Date:  2002-01       Impact factor: 3.084

4.  Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta.

Authors:  Shyam A Patel; Justin R Meyer; Steven J Greco; Kelly E Corcoran; Margarette Bryan; Pranela Rameshwar
Journal:  J Immunol       Date:  2010-04-09       Impact factor: 5.422

5.  Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.

Authors:  Massimo Di Nicola; Carmelo Carlo-Stella; Michele Magni; Marco Milanesi; Paolo D Longoni; Paola Matteucci; Salvatore Grisanti; Alessandro M Gianni
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

6.  Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages.

Authors:  Jaehyup Kim; Peiman Hematti
Journal:  Exp Hematol       Date:  2009-09-20       Impact factor: 3.084

7.  A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.

Authors:  Joshua M Hare; Jay H Traverse; Timothy D Henry; Nabil Dib; Robert K Strumpf; Steven P Schulman; Gary Gerstenblith; Anthony N DeMaria; Ali E Denktas; Roger S Gammon; James B Hermiller; Mark A Reisman; Gary L Schaer; Warren Sherman
Journal:  J Am Coll Cardiol       Date:  2009-12-08       Impact factor: 24.094

8.  Combining neuropeptide Y and mesenchymal stem cells reverses remodeling after myocardial infarction.

Authors:  Yigang Wang; Dongsheng Zhang; Muhammad Ashraf; Tiemin Zhao; Wei Huang; Atif Ashraf; Ambikaipakan Balasubramaniam
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-11-06       Impact factor: 4.733

9.  Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.

Authors:  Hua Pan; Kefeng Zhao; Lu Wang; Yan Zheng; Guoyou Zhang; Haixing Mai; Yan Han; Li Yang; Shuzhong Guo
Journal:  J Surg Res       Date:  2008-11-04       Impact factor: 2.192

10.  Ablation of TNF-alpha receptors influences mesenchymal stem cell-mediated cardiac protection against ischemia.

Authors:  Jiangning Tan; Brent R Weil; Aaron M Abarbanell; Yue Wang; Jeremy L Herrmann; Megan L Dake; Daniel R Meldrum
Journal:  Shock       Date:  2010-09       Impact factor: 3.454

View more
  9 in total

1.  Effects of mesenchymal stem cell and fibroblast coating on immunogenic potential of prosthetic meshes in vitro.

Authors:  Yue Gao; David M Krpata; Cory N Criss; Lijia Liu; Natasza Posielski; Michael J Rosen; Yuri W Novitsky
Journal:  Surg Endosc       Date:  2014-06-28       Impact factor: 4.584

Review 2.  Mesenchymal stem cells as a therapeutic tool to treat sepsis.

Authors:  Eleuterio Lombardo; Tom van der Poll; Olga DelaRosa; Wilfried Dalemans
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

3.  The Mechanisms Involved in Mesenchymal Stem Cell Alleviation of Sepsis-Induced Acute Lung Injury in Mice: A Pilot Study.

Authors:  Feng Luo; Wei Jiang; Yan Xu; Xue-Mei Liu; Wei Wang; Wei Zhang; Congjuan Luo
Journal:  Curr Ther Res Clin Exp       Date:  2020-07-08

4.  Monocrotaline-Induced Pulmonary Hypertension Involves Downregulation of Antiaging Protein Klotho and eNOS Activity.

Authors:  Rohan Varshney; Quaisar Ali; Chengxiang Wu; Zhongjie Sun
Journal:  Hypertension       Date:  2016-09-26       Impact factor: 10.190

5.  Mesenchymal stem cell therapy for cardiac repair.

Authors:  Rahul Thakker; Phillip Yang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-07

6.  Antioxidant Effects of Bone Marrow Mesenchymal Stem Cell against Carbon Tetrachloride-Induced Oxidative Damage in Rat Livers.

Authors:  M Ayatollahi; Z Hesami; A Jamshidzadeh; B Gramizadeh
Journal:  Int J Organ Transplant Med       Date:  2014

Review 7.  Turning regenerative technologies into treatment to repair myocardial injuries.

Authors:  Felicia Carotenuto; Laura Teodori; Anna Maria Maccari; Luciano Delbono; Giuseppe Orlando; Paolo Di Nardo
Journal:  J Cell Mol Med       Date:  2019-09-30       Impact factor: 5.310

8.  The Necessity of a Systematic Approach for the Use of MSCs in the Clinical Setting.

Authors:  Christophe Michel Raynaud; Arash Rafii
Journal:  Stem Cells Int       Date:  2013-06-23       Impact factor: 5.443

9.  The potential and challenges of using stem cells for cardiovascular repair and regeneration.

Authors:  Qisi Sun; Zhonge Zhang; Zhongjie Sun
Journal:  Genes Dis       Date:  2014-09-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.